Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-02

FDA Approved: TENOFOVIR DISOPROXIL FUMARATE — Original Application (Quinn Pharmaceuticals)

View source ↗

Summary

FDA approves an original ANDA for a generic tenofovir disoproxil fumarate from Quinn Pharmaceuticals for the treatment of HIV infection and chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)

Snippet

ORIG AP for TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR DISOPROXIL FUMARATE)